Jiangxi Fushine Pharmaceutical Co., Ltd. (300497.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap8.02B
Enterprise Value8.92B
P/E Ratio489.32
PEG Ratio3.08
Price/Sales Ratio6.17
Price/Book Ratio4.07
Enterprise/Revenue7.06
Enterprise/EBITDA35.86

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.08
Operating Margin0.1
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.06

Income Statement

Revenue1.18B
Revenue/Share2.89
Gross Profit151.26M
EBITDA145.68M
Net Income-55.03M
Diluted EPS-0.1

Balance Sheet

Total Cash492.4M
Total Cash/Share0.91
Total Debt1.87B
Total Debt/Equity0.79
Current Ratio1.28
Book Value Per Share4.44

Price History

52-Week Change79.5
52-Week High24.18
52-Week Low9.4
Moving Average 50 Days18.32
Moving Average 200 Days17.46

Statistics

Average Volume38.23M
Shares Outstanding538.65M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.05
Trailing Annual Dividend Yield0.28
Payout Ratio0.31
Last Split Factor8:5
Last Split DateMay 18, 2020
AD